Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu patentgeschützten Wirkstoffen-VV89
Description
Section 130a Paragraph 8 of the German Social Code Book V (SGB V) allows health insurance companies (KK) and pharmaceutical companies to conclude framework discount contracts for medicines to be dispensed at the expense of the statutory KK. The GWQ acts as the Society for Economy and Quality with KK according to Section 130a Paragraph 8 Sentence 5 SGB V for its shareholder and customer funds. With regard to the relevant legal provisions for the award of public contracts, a regular process of substance-related, formal tendering procedures according to the regulations of Part 4 of the German Competition Act (GWB) is carried out by the GWQ ServicePlus AG. The contract start date is 01.04.2026.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Angiography supplies – DSA-Anlagen
Herz- und Diabeteszentrum NRWGermanyAngiography suppliesAngiography devicesDeadline in 23 daysPublished on Oct 22, 2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Perindopril/Amlodipin/Indapamid (ATC-Code nach WHO: C09BX01)
AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPharmaceutical productsDeadline in 645 daysPublished on Oct 22, 2026
Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-18
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 767 daysPublished on Oct 22, 2026
Germany – Renal support devices – Akutdialysegeräte - Hämofiltration, Verbrauchsmaterialien und Service
Klinikum der Ludwig-Maximilians-Universität München (LMU Klinikum)GermanyRenal support devicesRenal dialysis consumablesRepair and maintenance services of medical equipmentDeadline in 15 daysPublished on Oct 22, 2026